Delivery Order SPE2DB20D1004-SPE2DB24FF2K2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,253.54 firm-fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of July 13, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a...
- This federal contract award, valued at $5,169.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, with a completion date of December 11, 2023. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The $2,787.57 Firm Fixed Price Delivery Order is for the supply of Trelegy Ellipta 200-62.5-25 60S medication. The contract has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,463.97 firm fixed-price delivery order is for the medication TRELEGY ELLIPTA 100-62.5-25 60S. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Trelegy Ellipta 100-62.5-25 60s medication. The firm-fixed-price delivery order, valued at $2,316.54, has an ultimate completion date of September 27, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,173.78 firm-fixed-price delivery order is for the medication Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of August 3, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,517.51 firm fixed-price delivery order is for the medication Trelegy Ellipta 200-62.5-25 60S. The contract has an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,417.89 firm-fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of May 16, 2023. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and...
- This federal contract award, valued at $5,080.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. The contract is a firm fixed-price delivery order with an ultimate completion date of November 9, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,804.74, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of May 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a significant...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FF2K2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,584.51, is for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. The contract has an ultimate completion date of January 19, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 1/18/24 |